CBIH Signs First VitaCookies Licensing Deal, Initiating Commercial Rollout
CBIH sits 50% above its 52-week low of $0 on light trading volume (0.3× avg).
Summary
Cannabis Bioscience International Holdings (CBIH) announced its first licensing agreement for its VitaCookies product with NCAS, LLC. This marks a significant step for the micro-cap company, moving VitaCookies from internal development to commercial execution and establishing a new revenue pathway. While specific financial terms were not disclosed, this agreement provides a foundation to test market response and refine CBIH's licensing model, with initial focus on Dallas and Houston.
At the time of this announcement, CBIH was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.00 to $0.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.